H. Westphal

Insider Reports History

Entity
Individual
Location
C/O Alnylam Pharmaceuticals, Inc, 300 Third Street, Cambridge, MA
Signature
/s/ Christoph Westphal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by H. Westphal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TScan Therapeutics, Inc. 10%+ Owner Voting Common Stock 1.28M $6.35M $4.97 Jul 20, 2021 Indirect
TScan Therapeutics, Inc. 10%+ Owner Voting Common Stock 915K $4.54M $4.97 Jul 20, 2021 Direct
TScan Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Jul 20, 2021 Indirect
TScan Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 20, 2021 Indirect
TScan Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 Jul 20, 2021 Indirect

Insider Reports Filed by H. Westphal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRX TScan Therapeutics, Inc. Jul 20, 2021 5 $2M 4 Jul 22, 2021 10%+ Owner
TCRX TScan Therapeutics, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 Director, 10%+ Owner